Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-04
2006-07-04
Hartley, Michael (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S279000, C424S464000
Reexamination Certificate
active
07071202
ABSTRACT:
A polymorphic form of 9-nitrocamptothecin is provided, the polymorph being characterizable as having, by differential scanning calorimetry, no observable endotherm and an exotherm at between 273.6 and 275.6° C., and a solution NMR spectrum with multiplets at 1.7 and 3.7 ppm shifts.
REFERENCES:
patent: 5162532 (1992-11-01), Comins et al.
patent: 5922877 (1999-07-01), Cao
patent: 6288072 (2001-09-01), Wall et al.
patent: 6291676 (2001-09-01), Burke et al.
patent: 6482830 (2002-11-01), Redkar et al.
patent: 6492379 (2002-12-01), Redkar et al.
Gore Ashok
Redkar Sanjeev
Hartley Michael
SuperGen, Inc.
Wilson Sonsini Goodrich & Rosati
Young Micah-Paul
LandOfFree
Compositions and formulations of 9-nitrocamptothecin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and formulations of 9-nitrocamptothecin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and formulations of 9-nitrocamptothecin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3556655